|
1
|
Smith HO, Berwick M, Verschraegen CF,
Wiggins C, Lansing L, Muller CY and Qualls CR: Incidence and
survival rates for female malignant germ cell tumors. Obstet
Gynecol. 107:1075–1085. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mahdi H, Kumar S, Seward S, Semaan A,
Batchu R, Lockhart D, Tamimi H and Munkarah AR: Prognostic impact
of laterality in malignant ovarian germ cell tumors. Int J Gynecol
Cancer. 21:257–262. 2011.PubMed/NCBI
|
|
3
|
Roychoudhuri R, Putcha V and Møller H:
Cancer and laterality: A study of the five major paired organs
(UK). Cancer Causes Control. 17:655–662. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gershenson DM: Management of ovarian germ
cell tumors. J Clin Oncol. 25:2938–2943. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sigismondi C, Scollo P, Ferrandina G,
Candiani M, Angioli R, Viganò R, Scarfone G and Mangili G:
Management of bilateral malignant ovarian germ cell tumors: A
MITO-9 retrospective study. Int J Gynecol Cancer. 25:203–207. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fritz A, Percy C, Jack A, Shanmugaratnam
K, Sobin L, Parkin DM and Whelan S: International Classification of
Diseases for Oncology (ICD-O) (3rd). World Health Organization.
Geneva, Switzerland: 2013.
|
|
7
|
Mutch DG and Prat J.: 2014 FIGO staging
for ovarian, fallopian tube and peritoneal cancer. Gynecol Oncol.
133:401–404. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Husaini ALH, Soudy H, El Din Darwish A,
Ahmed M, Eltigani A, Mubarak ALM, Sabaa AA, Edesa W, L-Tweigeri AT
and Al-Badawi IA: Pure dysgerminoma of the ovary: A single
institutional experience of 65 patients. Med Oncol. 29:2944–2948.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Brewer M, Gershenson DM, Herzog CE,
Mitchell MF, Silva EG and Wharton JT: Outcome and reproductive
function after chemotherapy for ovarian dysgerminoma. J Clin Oncol.
17:2670–2675. 1999.PubMed/NCBI
|
|
10
|
Dimopoulos MA, Papadopoulou M,
Andreopoulou E, Papadimitriou C, Pavlidis N, Aravantinos G,
Aspropotamitis A, Anagnostopoulos A, Fountzilas G, Michalas S and
Pectacides D: Favorable outcome of ovarian germ cell malignancies
treated with cisplatin or carboplatin-based chemotherapy: A
Hellenic Cooperative Oncology Group Study. Gynecol Oncol. 70:70–74.
1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Vicus D, Beiner ME, Klachook S, Le LW,
Laframboise S and Mackay H: Pure dysgerminoma of the ovary 35 years
on: A single institutional experience. Gynecol Oncol. 117:23–26.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin KY, Bryant S, Miller DS, Kehoe SM,
Richardson DL and Lea JS: Malignant ovarian germ cell tumor - role
of surgical staging and gonadal dysgenesis. Gynecol Oncol.
134:84–89. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Jonson AL, Geller MA and Dickson EL:
Gonadal dysgenesis and gynecologic cancer. Obstet Gynecol.
116(Suppl 2): S550–S552. 2010. View Article : Google Scholar
|
|
14
|
Canto P, Söderlund D, Reyes E and Méndez
JP: Mutations in the desert hedgehog (DHH) gene in patients with
46,XY complete pure gonadal dysgenesis. J Clin Endocrinol Metab.
89:4480–4483. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Funato T, Uehara S, Takahashi M, Kozawa K,
Satoh J, Sasaki T and Kaku M: Microsatellite instability in gonadal
tumors of XY pure gonadal dysgenesis patients. Int J Gynecol
Cancer. 12:192–197. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bianco S, Agrifoglio V, Mannino F, Cefalù
E and Cittadini E: Successful pregnancy in a pure gonadal
dysgenesis with karyotype 46,XY patient (Swyer's syndrome)
following oocyte donation and hormonal treatment. Acta Eur Fertil.
23:37–38. 1992.PubMed/NCBI
|
|
17
|
Cicin I, Saip P, Guney N, Eralp Y, Ayan I,
Kebudi R and Topuz E: Yolk sac tumours of the ovary: Evaluation of
clinicopathological features and prognostic factors. Eur J Obstet
Gynecol Reprod Biol. 146:210–214. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Nawa A, Obata N, Kikkawa F, Kawai M,
Nagasaka T, Goto S, Nishimori K and Nakashima N: Prognostic factors
of patients with yolk sac tumors of the ovary. Am J Obstet Gynecol.
184:1182–1188. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurman RJ and Norris HJ: Embryonal
carcinoma of the ovary: A clinicopathologic entity distinct from
endodermal sinus tumor resembling embryonal carcinoma of the adult
testis. Cancer. 38:2420–2433. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Heo EJ, Choi CH, Park JM, Lee JW, Bae DS
and Kim BG: Primary ovarian choriocarcinoma mimicking ectopic
pregnancy. Obstet Gynecol Sci. 57:330–333. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Koo HL, Choi J, Kim KR and Kim JH: Pure
non-gestational choriocarcinoma of the ovary diagnosed by DNA
polymorphism analysis. Pathol Int. 56:613–616. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ozturk E, Ugur MG, Cebesoy FB, Aydin A,
Sever T and Balat O: Good prognosis for primary ovarian pure
nongestational choriocarcinoma using the EMA/CO regime. Eur J
Gynaecol Oncol. 31:123–125. 2010.PubMed/NCBI
|
|
23
|
Wan J, Li XM and Gu J: Primary
choriocarcinoma of the fallopian tube: A case report and literature
review. Eur J Gynaecol Oncol. 35:604–607. 2014.
|
|
24
|
Beiner ME, Gotlieb WH, Korach Y, Shrim A,
Stockheim D, Segal Y, Fridman E and Ben-Baruch G: Cystectomy for
immature teratoma of the ovary. Gynecol Oncol. 93:381–384. 2004.
View Article : Google Scholar : PubMed/NCBI
|
